The diagnostic accuracy of PI-RADS v2 for clinically significant cancer was evaluated by using whole-mount step-section slides as standard of reference. All significant cancers could be identified and the accuracy of PI-RADS 3 to 5 for predicting significant cancer was 91.7%, with high sensitivity (100%) and negative predictive value (100%).
This abstract and the presentation materials are available to members only; a login is required.